Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff

CompletedOBSERVATIONAL
Enrollment

845

Participants

Timeline

Start Date

May 14, 2020

Primary Completion Date

August 15, 2020

Study Completion Date

August 15, 2020

Conditions
Sars-CoV2
Interventions
DIAGNOSTIC_TEST

Anti-SARS-CoV2 Serology

A blood sample is collected by venipuncture at Day 0, Day 30 and Day 60. The anti-SARS-CoV2 serological status is measured by automated microplate ELISA technique on the EVOLIS analyzer (Biorad®), using reagent kits from EUROIMMUN France.

OTHER

Questionnaire

"Data concerning personal exposure factors are collected in a questionnaire:~* Socio-demographic factors: sex, age~* Professional factors: Employment (type, pace, reception, service, care practices), wearing of personal protective equipment (type of equipment, frequency of use) and type of hospital~* Non-professional factors: Contact with infected individuals, carrying of professional equipment and compliance with barrier measures"

Trial Locations (2)

33882

Hôpital d'Instruction des Armées Robert Picqué, Villenave-d'Ornon

83800

Hôpital d'Instuction des Armées Sainte-Anne, Toulon

All Listed Sponsors
lead

Direction Centrale du Service de Santé des Armées

OTHER

NCT04387838 - Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff | Biotech Hunter | Biotech Hunter